Foscarnet as treatment for cytomegalovirus retinitis following bone marrow transplantation
Related Experiment Videos
P S Ganly1, C Arthur, J M Goldman
1Department of Haematology, Hammersmith Hospital, London, UK.
Postgraduate Medical Journal
|May 1, 1988
Abstract:
This report describes a patient with chronic granulocytic leukaemia who developed cataracts on busulphan treatment. Following allogeneic bone marrow transplantation, he developed cytomegalovirus retinitis, which was treated successfully with trisodium phosphonoformate (foscarnet). Cytomegalovirus retinitis and its therapy, and busulphan-induced cataract are discussed.